0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Single Nucleotide Polymorphism"

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
From
EUR$1,500USDGBP
From
EUR$1,500USDGBP
From
EUR$1,500USDGBP
DNA Sequencing - Technologies, Markets & Companies - Product Thumbnail Image

DNA Sequencing - Technologies, Markets & Companies

  • Report
  • November 2021
  • 545 Pages
  • Global
From
EUR$4,000USDGBP
Cytogenetics - Technologies, Markets & Companies - Product Thumbnail Image

Cytogenetics - Technologies, Markets & Companies

  • Report
  • November 2021
  • 233 Pages
  • Global
From
EUR$2,500USDGBP
Personalized Medicine - Scientific & Commercial Aspects - Product Thumbnail Image

Personalized Medicine - Scientific & Commercial Aspects

  • Report
  • November 2021
  • 1165 Pages
  • Global
From
EUR$6,000USDGBP
Precision Medicine in Oncology. Edition No. 1 - Product Thumbnail Image

Precision Medicine in Oncology. Edition No. 1

  • Book
  • October 2020
  • 288 Pages
EUR$231USDGBP
EUR$193USDGBP
EUR$154USDGBP
Loading Indicator

Single Nucleotide Polymorphism (SNP) is a type of genetic variation that occurs when a single nucleotide in the genome sequence is altered. SNPs are the most common type of genetic variation among individuals and are used in genomics to identify genetic differences between individuals. SNP analysis is used to identify genetic markers associated with diseases, to study the genetic basis of complex traits, and to identify genetic variants associated with drug response. SNP analysis is used in a variety of applications, including personalized medicine, pharmacogenomics, and population genetics. SNP analysis is also used in the development of diagnostic tests, drug discovery, and gene therapy. SNP analysis is also used in the development of genetic tests for disease risk assessment and in the development of genetic tests for disease diagnosis. The SNP market is a rapidly growing market, driven by the increasing demand for personalized medicine and the development of new technologies for SNP analysis. Companies in the SNP market include Illumina, Thermo Fisher Scientific, BGI, and Genomics plc. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more